Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000875320-08-000044
Filing Date
2008-06-19
Accepted
2008-06-19 16:42:00
Documents
1
Period of Report
2008-06-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2443
  Complete submission text file 0000875320-08-000044.txt   4177
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139
Business Address 617-444-6589
Lewis-Hall Freda C (Reporting) CIK: 0001437909 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19319 | Film No.: 08908116